Author Archives: admin


Platelet Rich Plasma – L.A. Beauty Skin Center

Is your skin tone simply not as healthy and smooth as on previous occasions? Have you noted fine lines and sagging skin around your eyes, cheeks and mouth? Are you conscious of the puffiness and dark circles below your eyes? The best recommended solution to these types of skin issues is Platelet Rich Plasma therapy. PRP is an advanced treatment technology that utilizes ingredients present in an individuals blood in order to regenerate their skin and revitalize collagen, leading to healthy, young looking skin.

Platelet Rich Plasma has a protracted history of being applied in dentistry, reconstructive surgery and orthopedic medicine. Today, it is also being used in other branches of medicine including dermatology, cosmetic facial rejuvenation and skin wound healing. Scientific studies ever since have proven that PRP generates new collagen when infused into the skin and recent studies reveal that PRP can ease sun damage as well as aging skin problems.

PRP is basically a natural product produced from your own body. Through a simple blood draw, a little amount of blood is drawn from an individual into a sterile tube. Using a unique centrifuge machine, the blood is spun down in order to take out and concentrate the stem cells, growth factors and platelets that are very important for tissue healing. This little amount of blood with a high concentration of platelets and growth factors is referred to as Platelet Rich Plasma (PRP).

PRP is best known for its wonderful act of skin rejuvenation. When PRP is injected into particular parts of the skin, its high platelet concentration functions as a matrix that stimulates the growth of new collagen, revitalizes skin tissue and hence leads to a naturally smooth and firm skin. As a result, PRP treatment gets rid of wrinkles and creates a smoother skin feel and tone.

There is a huge difference between PRP therapy and other skin injections of fillers. Most fillers including Juvederm and Restylane are composed of solid material which fills skin lines and folds. They often last for short period of time and require repeated treatments to seal the area yet again. On the other hand, PRP fuels collagen growth for absolute facial rejuvenation instead of individual wrinkle enhancement. Platelet Rich Plasma therapy is recommended for faces that appear drawn, to soften below eye puffiness, enhance the overall skin tone, texture and tightness and seal skin areas where fillers are not able to reach. Fillers such as Juvederm and Restylane can be applied together with PRP given that the two forms of skin treatment actually serve different purposes. The fillers will fill particular wrinkles while PRP will enhance overall wrinkle improvement.

There is enough evidence to show that Platelet Rich Plasma can be used to treat several skin issues such as Diabetic foot ulcers, bedsores, thermal burns, hair loss, superficial and surgical injuries and skin graft donor sites. Others include facial rejuvenation and post-traumatic scars.

For optimal results, LA Beauty Skin Center is the best place to have your PRP cosmetic treatment. Improvement of the skin tone and elasticity will be visible immediately after treatment. To maintain your skin and face looking young, make follow-up PRP treatments at LA Beauty Skin Center.

Current Price

Full Face + micro needling $950

Read the original:
Platelet Rich Plasma - L.A. Beauty Skin Center

Cell-treatment Home

Cell-treatment.net is a domain which I- your editor Fas Kuiters- has owned from quite some time. Since 2009 I believe.

The primary purpose of ownership of the domain name at the time- and still is- is, to describe the developments in the Regenerative Medicine world, which for me is congruent to the developments in the world of Adult Stem Cell Therapy.

The predecessor of Cell-treatment.net was online for about 4 years, until I decided to take the website off-line in 2013, since things did not go very well in the industry and the developments for the core target group, I was aiming at, at the time- patients looking for relief and cures & the general public interested in the plight of those patients- were kind of chaotic in view of regulatory agencies around the world trying to establish their footing with those regulatory frameworks.

We are now end July 2016 whilst I write these words and I can see progress and if you like, "light" at the end of the tunnel all across the Globe in respect of those regulatory procedings.

Follow this link:
Cell-treatment Home

Generation of Neural Crest-Like Cells From Human …

Neural crest cells (NCC) hold great promise for tissue engineering, however the inability to easily obtain large numbers of NCC is a major factor limiting their use in studies of regenerative medicine. Induced pluripotent stem cells (iPSC) are emerging as a novel candidate that could provide an unlimited source of NCC. In the present study, we examined the potential of neural crest tissue-derived periodontal ligament (PDL) iPSC to differentiate into neural crest-like cells (NCLC) relative to iPSC generated from a non-neural crest derived tissue, foreskin fibroblasts (FF). We detected high HNK1 expression during the differentiation of PDL and FF iPSC into NCLC as a marker for enriching for a population of cells with NCC characteristics. We isolated PDL iPSC- and FF iPSC-derived NCLC, which highly expressed HNK1. A high proportion of the HNK1-positive cell populations generated, expressed the MSC markers, whilst very few cells expressed the pluripotency markers or the hematopoietic markers. The PDL and FF HNK1-positive populations gave rise to smooth muscle, neural, glial, osteoblastic and adipocytic like cells and exhibited higher expression of smooth muscle, neural, and glial cell-associated markers than the PDL and FF HNK1-negative populations. Interestingly, the HNK1-positive cells derived from the PDL-iPSC exhibited a greater ability to differentiate into smooth muscle, neural, glial cells and adipocytes, than the HNK1-positive cells derived from the FF-iPSC. Our work suggests that HNK1-enriched NCLC from neural crest tissue-derived iPSC more closely resemble the phenotypic and functional hallmarks of NCC compared to the HNK1-low population and non-neural crest iPSC-derived NCLC. J. Cell. Physiol. 232: 402-416, 2017. 2016 Wiley Periodicals, Inc.

2016 Wiley Periodicals, Inc.

See the original post here:
Generation of Neural Crest-Like Cells From Human ...

Platelet-rich plasma: intra-articular knee injections …

Platelet-rich plasma (PRP) is a natural concentrate of autologous blood growth factors experimented in different fields of medicine in order to test its potential to enhance tissue regeneration. The aim of our study is to explore this novel approach to treat degenerative lesions of articular cartilage of the knee. One hundred consecutive patients, affected by chronic degenerative condition of the knee, were treated with PRP intra-articular injections (115 knees treated). The procedure consisted of 150-ml of venous blood collected and twice centrifugated: 3 PRP units of 5 ml each were used for the injections. Patients were clinically prospectively evaluated before and at the end of the treatment, and at 6 and 12 months follow-up. IKDC, objective and subjective, and EQ VAS were used for clinical evaluation. Statistical analysis was performed to evaluate the significance of sex, age, grade of OA and BMI. A statistically significant improvement of all clinical scores was obtained from the basal evaluation to the end of the therapy and at 6-12 months follow-up (P < 0.0005). The results remained stable from the end of the therapy to 6 months follow up, whereas they became significantly worse at 12 months follow up (P = 0.02), even if still significantly higher respect to the basal level (P < 0.0005). The preliminary results indicate that the treatment with PRP injections is safe and has the potential to reduce pain and improve knee function and quality of live in younger patients with low degree of articular degeneration.

Go here to see the original:
Platelet-rich plasma: intra-articular knee injections ...

UT Southwestern, Dallas, Texas – UTSW Medicine (Patient …

We Are Magnet

UT Southwestern has achieved Magnet designation, the highest honor bestowed by the American Nurses Credentialing Center (ANCC).

We've brought the leading-edge therapies and world-class care of UT Southwestern to Richardson/Plano, Las Colinas, and the Park Cities.

Clinical Center at Las Colinas The Las Colinas Obstetrics/Gynecology Clinic is a full-service practice, treating the full range of obstetric and gynecologic conditions.

Clinical Center at Park Cities The Clinical Center at Park Cities features cardiology, general internal medicine, obstetric/gynecologic, and rheumatology services.

Clinical Center at Richardson/Plano The Clinical Center at Richardson/Plano features behavioral health, cancer, neurology, obstetric/gynecologic, primary care, sports medicine, and urology services.

UT Southwestern Medical Center is honored frequently for the quality of our care and the significance of our discoveries. Some of our recent awards include the Press Ganey Beacon of Excellence Award for patient satisfaction and the National Research Consultants' Five Star National Excellence Award.

Visit link:
UT Southwestern, Dallas, Texas - UTSW Medicine (Patient ...

Guest View: No to embryonic stem cells – htrnews.com

Pat Langlois 5:33 p.m. CDT November 4, 2016

Culturing cells in small petri dishes(Photo: Hakat, Getty Images/iStockphoto)

In the Herald Times Reporter on Sunday, Oct. 16, 2016, you published a commentary titled Wisconsin a hotbed of stem cell issues by Howard Brown in which he promotes the use of embryonic stem cells. He indicates these cells are isolated five to 10 days after conception. They are not yet a baby, he states.

Conception in Tabers Cyclopedic Medical Dictionary is The union of the male sperm and the ovum of the female; fertilization. The union signifies that the life of a new human being has begun. This union will continue its process of development and move through the various stages of development including embryo, fetus, newborn, toddler, school age, teenager, adult and old age. Never in that process is this human being anything but human.

OPINION:Voting is a gift from our Founders: Norman Lear

OPINION:Doctors: We can do better than Obamacare

Human embryologist C. Ward Kischer, an associate professor emeritus at the University of Arizona, stated: Every human embryologist in the world knows that the life of the new individual human being begins at fertilization. It is not a belief. It is a scientific fact.

Therefore, because it is a new human, it deserves our respect and protection.

To say, as he did it is not yet a baby is wrong language semantics in an effort to camouflage the truth. It is a baby in its earliest stage of development.

Brown indicates it is OK to use embryos (his word) from in vitro fertilization donated by parents for research when the parents decided not to use them to produce a baby. Those embryos are the baby. How can we sooth our consciences by using word gymnastics to justify experimentation on a defenseless human being? These embryos are our next generation. They are of great value.

The author indicates embryonic stem cells show promise in beating diseases. But there is the complication of uncontrolled tumor formation and rejection.

Adult stem cells have been used for years to treat more than 100 conditions, including leukemia, cancerand immune system disorders.

Adult stem cells can come from the patients own tissues including bone marrow, blood, muscleand nasal mucosa. These cells are not genetically unstable, so the risk of tumors is eliminated and the problem of rejection does not exist. More than 1,500 clinical studies have been conducted testing adult stem cells for treating diabetes, heart disease, MS, arthritis, etc.

His final statement asks, where does the reader stand on the use of embryonic stem cells no longer wanted for in vitro fertilization? The fact remains that these embryos are human beings. They are not a resource that can be used for experimentation. They are fellow human beings deserving of our protection until natural death, just like you and I.

The emphases of our research should be centered around adult stem cell treatments and cures. It is ethical and has shown great promise.

Read or Share this story: http://htrne.ws/2fnYvcE

Read the original post:
Guest View: No to embryonic stem cells - htrnews.com

Embryonic Stem Cell Research – rtl.org

pdf version for easy printing

Right to Life of Michigan is opposed to research which destroys a developing human being. When stem cells are removed from human embryos, a unique individual dies. It has been proven scientifically that human life begins at conception. This fact sheet on stem cell research contains information about stem cells and their potential. It also describes the current legal situation regarding human embryonic stem cell research and federal funding, as well as information about ethical alternatives such as research on adult stem cells and blood from the umbilical cord which have provided actual treatments to patients.

What are stem cells and what is their potential?

Stem cells are the cells from which all other cells originate. In a human embryo, a large portion of the embryos cells are stem cells. As the young child grows in her mothers womb, most of these cells begin to differentiate and become the heart, liver, kidneys and all of the 210 kinds of tissue found in a human body.(1) Even though most of these cells become differentiated, all humans retain some stem cells. Stem cells are incredibly versatile cells that can be replicated indefinitely. These cells, given the correct cues, can develop into specialized cells which the body might need. Most of the potential good such research may produce has revolved around the use of stem cells from human embryos, but there is also research being done on adult stem cells, stem cells from umbilical cord blood, and induced pluripotent stem cells.

Since stem cells are so versatile and there are many diseases that result from the lack of or dysfunction of a single type of cell, there is hope within the medical community that someday cells can be reprogrammed to cure various diseases. Some of these diseases include Parkinsons, diabetes, spinal cord injuries, and heart disease.

There are many sources for stem cells. In adults, stem cells can be found in numerous kinds of tissues and organs including bone marrow, blood, fat, skin, the liver, and even baby teeth.(2) Another ethical source of stem cells is the blood found in umbilical cords and placentas after birth. Stem cells removed from these sources dont harm the patient.

Despite these multiple sources of stem cells, most of the medias attention is focused on embryonic stem cells.(3) These are cells that would eventually become a childs organs and tissues but are removed from a human embryo in the first week of life. When these cells are removed, a human embryo dies.

Advocates for human embryonic stem cell research want to use embryos that have been frozen at fertility clinics as the main source of embryonic stem cells. These leftover embryos were conceived to bring about an in vitro fertilization pregnancy, but they were never implanted into their mothers womb. When a woman gets pregnant with in vitro fertilization and not all of the embryos are implanted, fertility clinics allow couples to destroy them, donate them to another couple, or freeze them in case they want to give birth to another child at a later time. Most couples freeze their embryonic children to save them for later birth attempts.(4)

Some scientists have gone a step further by creating embryos whose sole purpose is to be used for research while others have used cloning to create human embryos that can be killed for their stem cells.

Federal funding of human embryonic stem cells research

In August 2000, the National Institutes of Health (NIH) and the Department of Health and Human Services (DHHS) determined that federal funds could be legally used to support research on human embryonic stem cells, despite a federal law forbidding federal funding of research that destroys human embryos. Passed in 1996, the Dickey-Wicker Amendment states that federal funds cant be used for research in which a human embryo or embryos are destroyed, discarded, or knowingly subjected to risk of injury or death.

The NIH avoided this law by using the DHHSs rationale that stem cells arent embryos, so research using stem cells is separated from the act of obtaining those stem cells by destroying an embryo. The NIH stated that federal funds would not be used for the actual removal of the stem cells from the embryo (which kills the embryo). However, once stem cells are removed from the embryo, the NIH would provide federal funds.

The problem with the NIH Guidelines is that in order to do research on embryonic stem cells, embryos have to be destroyed. There is no way of separating the two. By providing federal funds for research on embryonic stem cells, the NIH is promoting the destruction of innocent lives.

The language of the Dickey-Wicker Amendment is obviously intended to cover more than just research whose only purpose is the destruction of embryos. The language of the law implies that research where an embryo will be destroyed, including cases where this destruction will occur in order for the research to take place, should not receive federal funds.

Before any federal funding began, President George W. Bush sought a compromise soon after his election. On August 9, 2001, he announced that he would allow federal funds for the first time to be used for human embryonic stem cell research, but only on cell lines created before August 9, 2001. These stem cell lines were created from embryos that were destroyed before the presidents decision. On the positive side, President Bush also announced that he would allocate $250 million to research involving stem cells from non-controversial sources and took a strong stand against all forms of human cloning.

Shortly after taking office, President Barack Obama issued an executive order on March 9, 2009, to remove President Bushs funding restrictions and allow the federal government to fund research on human embryonic stem cells as long as the cell lines were taken from human embryos created by in vitro fertilization for reproductive purposes and were donated by their parents. The Dickey-Wicker Amendment is still on the books, but its original intent continues to be violated.

Alternatives to human embryo research

The search for treatments and cures need not include the destruction of innocent, vulnerable human embryos. Stem cell research can move forward, alternatives to human embryonic stem cells exist.

The most promising of these alternative methods is the use of adult stem cells. Initially, adult stem cell research was not extensive because adult stem cells were thought to be less available and versatile, however, recent reports continue to show the usefulness of adult stem cells. Adult stem cells have been shown to form different tissues, including muscle, fat, cartilage and bone.(5) American and Brazilian researchers were able to use bone marrow stem cells to help 20 of 23 type-1 diabetic patients become insulin-free for a period of time.(6) Adult stem cells have already been used clinically while embryonic stem cells have yet to cure a single patient. It is also important to point out that adult stem cells taken from a persons own body dont face the risk of being rejected by the patients immune system, unlike embryonic stem cells.(7)

Proponents of embryonic stem cell research have tried to get around this problem by advocating therapeutic cloning where the patient is cloned and then stem cells from the cloned embryo are removed and transplanted.(8)

Another promising alternative to embryonic stem cell research that doesnt have ethical implications is research on stem cells found in the blood of umbilical cords. The small amount of blood found in umbilical cords after birth is rich in stem cells. Private companies and some states have cord blood banks where the stem cells can be saved for future use. Michigan Blood operates a public cord blood bank where anyone can easily donate cord blood as a part of the birthing process.

Despite ethical alternatives, many researchers still insist that embryonic stem cells are superior because they can turn into any cell in the human body. Another alternative allows all of the supposed benefits of embryonic stem cells without destroying human life. Induced pluripotent stem cells (iPS cells) are ordinary human skin cells that have been reverted back to an embryonic-like state by genetic reprogramming. Creating iPS cells does not harm the patient and requires no destruction of human life.(9)

These cells are pluripotent, like those taken from destroyed human embryos, which means they have the potential to change into any type of tissue in the body. The original process for making iPS cells was discovered in November of 2007 and experiments are ongoing.

Like embryonic stem cells, iPS cells might share their risk of becoming cancer cells if they dont differentiate and grow properly. Another avenue of research being worked on is direct cell reprogamming, where scientists change a cell type without having to go through a stem cell stage, for example turning skin cells directly into blood cells.(10)

How stem cells from ethical sources have helped

While some scientists talk about the potential of embryonic stem cells, stem cells from umbilical cords and adults are already helping people. Many stories about ethical stem cell treatments arent widely discussed or make the national evening news but they are important breakthroughs for life-affirming research. Following is a list of just recent breakthroughs in research involving types of stem cells that dont require innocent human life to be sacrificed:

On May 21, 2015, FOX News reported that 29 stroke patients who recieved their own bone marrow stem cells were noted to recover motor skills and speech. The study showed that it is safe to inject the bone marrow stem cells directly by catheter through the carotid artery. On June 2, 2014, the Providence Journal in Rhode Island reported the stories of several people whose lives were saved by bone marrow stem cell treatments for their leukemia from marrow donors. The stories included a retired police office who recieved his transplant in 2011, and another man who received his transplant in 1998 after chemotherapy and a relapse. On May 5, 2014, Forbes reported on a review by the Cochrane Collaboration of 23 studies that looked at bone marrow stem cell treatments for heart disease. They found that overall, the treatments reduced the risk of death and improved heart function. Of the six studies that reported on long-term results more than a year after treatments, 3.3 percent of patients died following the adult stem cell treatments, compared to 18.5 percent who did not. On October 28, 2013, FOX 45 in Baltimore reported on the story of a Maryland man who was able to walk again following treatment using adult stem cells from bone marrow. He was paralzyed from the chest down from transverse myelitis caused by lupus.

On April 30, 2013, USA Today reported that a two-year-old girl in South Korea received an artificial windpipe made from plastic and adult stem cells taken from her own bone marrow. The experimental procedure appears to be successful so far. The girl has been unable to eat or breathe since birth. On January 28, 2013, The Daily Mail reported on a small British study that found that treating cartilage damage with umbilical cord blood stem cells led to a 67 percent improvement in tissue regeneration in patients. Other clinical trials using the procedure are ongoing.

Killing embryos for research legal in Michigan

In 2008, Michigan voters passed Proposal 2 by a margin of 53% to 47%. Proposal 2 was a ballot initiative which amended the Michigan Constitution to allow the killing of and research on human embryos who were created for fertility treatments. The language in Proposal 2 also deters legislation which would prevent, restrict, obstruct, or discourage or create disincentives for individuals who want to perform research on human embryos. Proposal 2 was supported by embryonic stem cell researchers in Michigan because, prior to Proposal 2, a 1978 law outlawed research on human embryos if that research wasnt designed to benefit the subject of the research (the embryo).

The option of embryo adoption

One of the main arguments behind embryonic stem cell research is that all of the embryos will be destroyed anyway. Why not use them to help cure diseases? Fortunately, these unique individuals dont need to die. Nightlight Christian Adoptions, a California-based adoption agency has a program called Snowflakes Embryo Adoption that allows couples to adopt leftover embryos. Parents of children who were adopted as embryos held a press conference in Washington, D.C., on March 9, 2009, to show President Obama and members of Congress that leftover embryos can grow if given the chance.

As of June 2015, there were 418 born children who were adopted via the Snowflakes Embryo Adoption program. Snowflakes is one of several adoption programs which facilitates embryo adoption. Some believe that stem cells from embryos are human enough for research, but not human enough to join the human family. This logic defies the reality that life begins at conception, a truth some researchers and politicians would like to ignore.

The ethics of embryonic stem cell research

One of the most important issues in the debate over stem cell research is the ethics involved. Taking the life of a human being at any stage in development for research is ethically wrong. The embryos that are being destroyed are more than just tissue. These unborn children already are alive and have the genetic blueprint that they will have for the rest of their lives. The stem cells that are taken from them would have eventually developed into, among other things, their hearts, brains, livers, and kidneys.

It is never ethically correct to sacrifice the life of one human to save another without their consent. This kind of utilitarian thinking was the same kind of rationale used by Nazi scientists or during syphilis experiments on African-Americans in Tuskegee, Alabama. Medical advancement should continue, but not through the taking of human life. No human being should be forced to be made the subject of research without their permission, especially if that research leads directly to their destruction. Even death row inmates cannot be experimented on or have their organs removed, without their consent.

Proponents of embryonic stem cell research often cite all of the potentials of the research but usually fail to mention that a human life is destroyed when stem cells are removed from an embryo. The goals of this research are noble, but that doesnt mean that we should abandon our respect for human life to attain these goals. Embryonic stem cell research is a case where the ends dont justify the means. The possibilities for stem cell research are enormous; however, we should focus on the options that protect and acknowledge all human life, not just some of it.

References: 1 - David Prentice, No Fountain of Youth, Regeneration Quarterly 6, no. 4 (2000): 14-16. 2 - Laura Wright, Potent Stem Cells Found in Baby Teeth, Scientific American, 23 April 2003. 3 - Wesley J. Smith, All the News Thats Fit to Forget, The Weekly Standard 17, no. 11 (2011). 4 - D.I. Hoffman et al., Cryopreserved Embryos in the United States and Their Availability for Research, Fertility and Sterility 79, no. 5 (2003): 1063-1069. 5 - Hysterectomies a stem cell source, BBC News, 17 June 2009. 6 - Stem cells can treat diabetes, BBC News, 15 April 2009. 7 - Immune Response May Hinder Stem Cell Treatments, HealthDay News, 18 August 2008. 8 - David Brown, Oregon scientists get stem cells from cloned human embryos, The Washington Post, 15 May 2013. 9 - Rob Stein, Researchers Create Cells That They Say May Be Equivalent to Embryonic Stem Cells, The Washington Post, 24 July 2009. 10 - Ewen Callaway, Cellular alchemy transforms skin into blood, Nature, 7 November 2010.

top

Read this article:
Embryonic Stem Cell Research - rtl.org

Leukemia & Lymphoma Society | Donate Today!

Do you know a hero or are one yourself? Submit your story for a chance to have your story included in the Community of Heroes for a common cause.

This field is required Select your state Alabama Alaska American Samoa Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Guam Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Northern Mariana Islands Ohio Oklahoma Oregon Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Virgin Islands Washington West Virginia Wisconsin Wyoming Alberta British Columbia Manitoba New Brunswick Newfoundland Northwest Territories Nova Scotia Nunavut Ontario Prince Edward Island Quebec Saskatchewan Yukon

This field is required

I hereby authorize and permit The Leukemia & Lymphoma Society or its authorized agent, without compensation therefore, permission to photograph, publish, reproduce, record and use, with or without my name or the name of the person for whom I am the parent/guardian. This includes but is not limited to photographs, quotes and/or text, motion pictures, videotapes, website information or audiotapes of and/or by me or the person for whom I am the parent/guardian. I release The Leukemia & Lymphoma Society from any and all legal liability that may arise from the release of information requested. I agree that all text, photographs, motion pictures, negatives, prints and transparencies, videotapes and audio tapes made of and or by me or the person for whom I am the parent/guardian by or for The Leukemia & Lymphoma Society, shall be the exclusive property of The Leukemia & Lymphoma Society which in its sole discretion may use this material as it sees fit.

* This field is required

* Please fix the validation error messages in the Form

Your story was not submitted due to a connection error. Please try again later.

Continue reading here:
Leukemia & Lymphoma Society | Donate Today!

Supercourse: Epidemiology, the Internet, and Global Health

ABCDEFGHIJKLMNOPQRSTUVWXYZ

Academic research council

Achievements public health

Achievements public health

Acne therapeutic strategies

Acute coronary symptoms

Acute coronary syndromes

Adenoviridae and iridoviridae

Adherence hypertension treatment

Administration management medical organizations

Adolescent health risk behavior

Adolescents reproductive health

Adolescents reproductive health

Adverse drug reactions

Advocacy strategy planning

African sleeping sickness

Aids/ hiv current senario

Airborne contaminants

Air pollution armenia

Air pollution armenia

American heart association

Aminoglycosidearginine conjugates

Analytic epidemiology

Anaplasmosis taxonomic

Anemia family practice

Anger regulation interventions

Antimicrobial resistance

Antimicrobrial peptides

Antiretroviral agents

Assessing disease frequency

Assessment bioterrorism threat

Assessment nutritional

Assistive technology devices

Attack preparedness events

Avian influenza: zoonosis

Bacterial membrane vesicles

Bacterial vaginosis pregnancy

Bases of biostatistics

Behaviour medical sciences

Betaserk treatment stroke

Bias confounding chance

Bimaristans (hospitals) islamic

Binomial distribution

Biochemical system medicine

Biological challenges

Biological epidemiologic studies

Biostatistics

Biostatistics public health

Blood donors non-donors

Blood glucose normaization

Bmj triages manuscripts

Body fluid volume regulation

Bolonya declaration education

Bone marrow transplantation

Breast self examination

Bronchial asthma treatmen

Building vulnerability

Burden infectious diseases

Burnout in physicians

Cncer en mxico

Cancer survivorship research

Canine monocytic ehrlichiosis

Capability development

Capture-recapture techniques

Cardiology practice grenada

Cardiometabolic syndrome

Cardiopulmonary resuscitation

Cardio-respiratory illness

Cardiovascular disease

Cardiovascular disease black

Cardiovascular disease prevention

Cardiovascular diseases

Cardiovascular system

Carpal tunnel syndrome

Caseous lymphadenitis

Cause epidemiological approach

Central nervous system

Cervical cancer screening

Changing interpretations

Chemical weapon bioterrorism

Chemiosmotic paradigm

Chickenpox children pregnancy

Child health kazakhstan

Childhood asthma bedding.

Childhood asthma prevalence

Childhood diabetes mellitus

Childhood hearing impairment

Children september 11th attacks

China

Chinese herbal medicines

Chns hypertension control

Cholera global health

Cholesterol education program

Chronic disease management

Chronic fatigue syndrome

Chronic liver disease

Chronic lung diseases

Chronic noncommunicable diseases

Chronic obstructive pulmonary disease

Chronic pulmonary heart

Read more here:
Supercourse: Epidemiology, the Internet, and Global Health

Generation of Induced Pluripotent Stem Cells with …

Induced pluripotent stem cells (iPSCs) share many characteristics with embryonic stem cells, but lack ethical controversy. They provide vast opportunities for disease modeling, pathogenesis understanding, therapeutic drug development, toxicology, organ synthesis, and treatment of degenerative disease. However, this procedure also has many potential challenges, including a slow generation time, low efficiency, partially reprogrammed colonies, as well as somatic coding mutations in the genome. Pioneered by Shinya Yamanaka's team in 2006, iPSCs were first generated by introducing four transcription factors: Oct 4, Sox 2, Klf 4, and c-Myc (OSKM). Of those factors, Klf 4 and c-Myc are oncogenes, which are potentially a tumor risk. Therefore, to avoid problems such as tumorigenesis and low throughput, one of the key strategies has been to use other methods, including members of the same subgroup of transcription factors, activators or inhibitors of signaling pathways, microRNAs, epigenetic modifiers, or even differentiation-associated factors, to functionally replace the reprogramming transcription factors. In this study, we will mainly focus on the advances in the generation of iPSCs with substitutes for OSKM. The identification and combination of novel proteins or chemicals, particularly small molecules, to induce pluripotency will provide useful tools to discover the molecular mechanisms governing reprogramming and ultimately lead to the development of new iPSC-based therapeutics for future clinical applications.

Original post:
Generation of Induced Pluripotent Stem Cells with ...